• Subscribe

    Webinars & Whitepapers →

    ▾
  • Xconomy National

  • Xperience
    Tech + Life
      • Fetch Rewards Grabs $25M, Plans to Double Staff as Growth Accelerates
        Fetch Rewards Grabs $25M, Plans to Double Staff as Growth Accelerates
      • Nuance Spinout Cerence Vies With Tech Giants in Voice-AI for Auto
        Nuance Spinout Cerence Vies With Tech Giants in Voice-AI for Auto
      • Can Ford’s Self-Driving Car Business Improve Austin’s Traffic Woes?
        Can Ford’s Self-Driving Car Business Improve Austin’s Traffic Woes?
      • John Halamka, Livongo Health & AI Progress at X·CON on Oct. 22
        John Halamka, Livongo Health & AI Progress at X·CON on Oct. 22
      • As More Grocers Embrace Tech, Swiftly Snags $15M to Launch in Seattle
        As More Grocers Embrace Tech, Swiftly Snags $15M to Launch in Seattle
      View More in Xperience ›
  • EXOME
    Biotech + Health
      • Iterum’s Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sink
        Iterum’s Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sink
      • Flagship’s Cellarity Aims to Advance Cell Behavior-Based Therapeutics
        Flagship’s Cellarity Aims to Advance Cell Behavior-Based Therapeutics
      • KalVista Pharma Eye Drug Partnered With Merck Flunks Phase 2 Test
        KalVista Pharma Eye Drug Partnered With Merck Flunks Phase 2 Test
      • Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules
        Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules
      • Scripps Research, AbbVie Expand Drug Discovery Deal Beyond Cancer
        Scripps Research, AbbVie Expand Drug Discovery Deal Beyond Cancer
      View More in EXOME ›
  • Our
    Regions
    • Boston ›
      • Flagship’s Cellarity Aims to Advance Cell Behavior-Based Therapeutics
        Flagship’s Cellarity Aims to Advance Cell Behavior-Based Therapeutics
      View More in Boston ›
    • Boulder/Denver ›
      • PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
        PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
      View More in Boulder/Denver ›
    • Detroit/Ann Arbor ›
      • Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal
        Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal
      View More in Detroit/Ann Arbor ›
    • Indiana ›
      • Eli Lilly Drug Acquired in Armo Deal Fails Pancreatic Cancer Test
        Eli Lilly Drug Acquired in Armo Deal Fails Pancreatic Cancer Test
      View More in Indiana ›
    • New York ›
      • Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules
        Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules
      View More in New York ›
    • Raleigh-Durham ›
      • Dova Pharmaceuticals Agrees to Sobi Acquisition, Shares Jump 38%
        Dova Pharmaceuticals Agrees to Sobi Acquisition, Shares Jump 38%
      View More in Raleigh-Durham ›
    • San Diego ›
      • Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules
        Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules
      View More in San Diego ›
    • San Francisco ›
      • BridgeBio Pharma Onboards Eli Wallace to Lead Oncology Programs
        BridgeBio Pharma Onboards Eli Wallace to Lead Oncology Programs
      View More in San Francisco ›
    • Seattle ›
      • A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns
        A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns
      View More in Seattle ›
    • Texas ›
      • Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing
        Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing
      View More in Texas ›
    • Wisconsin ›
      • AI Can Unlock Health Data's Potential, But Access Is Still Difficult
        AI Can Unlock Health Data's Potential, But Access Is Still Difficult
      View More in Wisconsin ›
  • Tech
    Channels
    • Agtech and Food›
      • With “Go,” Amazon Identifies Another Job It Can Do Better
      View More in Agtech and Food ›
    • Cleantech›
        View More in Cleantech ›
      • Cybersecurity›
          View More in Cybersecurity ›
        • Education›
            View More in Education ›
          • EXOME: Biotech + Health›
            • AstraZeneca, Novoheart to Co-Develop New Heart Model
              AstraZeneca, Novoheart to Co-Develop New Heart Model
            View More in EXOME ›
          • Fintech›
              View More in Fintech ›
            • Healthtech›
              • AI Can Unlock Health Data’s Potential, But Access Is Still Difficult
                AI Can Unlock Health Data’s Potential, But Access Is Still Difficult
              View More in Healthtech ›
            • Robotics and A.I.›
              • Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More
                Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More
              View More in Robotics and A.I. ›
            • Startups›
              • Five Questions With a16z’s Vijay Pande on AI and Making New Drugs
                Five Questions With a16z’s Vijay Pande on AI and Making New Drugs
              View More in Startups ›
            • Xperience: Tech + Life›
                View More in Xperience ›
            • Meet the
              Xconomists
              • Abigail Barrow

                Abigail Barrow

                Founding Director, Massachusetts Technology Transfer Center

              • Bill Clarke

                Bill Clarke

                Medical College of Wisconsin director of research commercialization

              • Andy Liu

                Andy Liu

                Co-Founder, BuddyTV

              • Alan Frazier

                Alan Frazier

                Founder and Managing Partner, Frazier Healthcare Ventures

              • Meet All the Xconomists ›
              • Carol Gallagher

                Carol Gallagher

                Partner at New Enterprise Associates

              • David Johnson

                David Johnson

                President and CEO of the Central Indiana Corporate Partnership

              • Chris Rizik

                Chris Rizik

                CEO and Fund Manager, Renaissance Venture Capital Fund

              • Desh Deshpande

                Desh Deshpande

                Founder and Chairman, Sycamore Networks

            • Our
              Events
              • All Xconomy Events › Boston Events ›
              • Boulder/Denver Events › Detroit/Ann Arbor Events ›
              • Indiana Events › New York Events ›
              • Raleigh-Durham Events ›San Diego Events ›
              • San Francisco Events ›Seattle Events ›
              • Texas Events › Wisconsin Events ›
            • Xpertise
              Watch + Learn

            “andrew-le” Archives

            in
            Entry Author Date Location
            John Halamka, Livongo Health & AI Progress at X·CON on Oct. 22 Jeff Bauter Engel 09/12/19 Boston
            Buoy Health, CVS Partner on Chatbot That Helps Patients Find Care Jeff Buchanan 05/08/18 Boston
            Froedtert Provides Patients with Symptom Checker from Boston Startup Jeff Buchanan 03/09/18 Wisconsin
            Pfizer, Veritas, MGH Join Xconomy’s Healthcare + A.I. Conference on Nov. 2 Gregory T. Huang 09/22/17 Boston
            Online Portals Challenge WebMD as Patients’ Source for Health Info Jeff Buchanan 09/14/17 Wisconsin
            Buoy Snags $6.7M for Chatbot, as A.I. Pushes Further Into Healthcare Jeff Buchanan 08/09/17 Boston
            Page 1 of 1

            Underwriters and Partners

            Xpertise: Watch + Learn
            • Potency Assay Development for Cell and Gene Therapy Products

              Sponsored · Whitepaper

              Potency Assay Development for Cell and Gene Therapy Products

              Create well-controlled, biologically relevant test systems and validate them to support FDA approvals

              Absorption Systems
            • Digitizing 10 Life Sciences Paper Processes

              Sponsored · Whitepaper

              Digitizing 10 Life Sciences Paper Processes

              How to accelerate your life sciences business with every agreement

              DocuSign
            • Robert Langer reveals secrets to early-stage biotech success

              From Our Partners · Special Report

              Robert Langer reveals secrets to early-stage biotech success

              Advice for funding and future transformational opportunities

            Connect with Xconomy

            • Xconomy on Facebook
            • Xconomy on Twitter
            • Xconomy on Linkedin
            • Xconomy on Google PLus
            • Xconomy Feeds

            Xconomy on Demand

            Did you miss something? Don't despair…

            Xconomy offers a number of ways to subscribe for free!

            Subscribe Now
            IDG Tech Network
            Protected by Carbonite
            Eventbrite - events made easy
            • Home
            • Privacy/DMCA
            • Security Disclosures
            • About
            • Contact Us
            • Archives
            • Advertise
            • Subscribe for Free

            Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.

            © 2007-2019, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

            Website development support from Andrew Koyfman with design support from Rob Hunter.